Our Network of Consultants

I have been working with hundreds of SMEs and supporting their owners and senior executives for over 10 years, helping them secure funding whether it be from Commercial Finance, Innovation Tax Incentives or Grants. In that time, I have become a source of trusted support to many clients. Access to finance has changed and continues to change - the traditional high street options are often time-consuming and ultimately unsuccessful. By working with me I can establish the specifics of your requirements and circumstances of the business, to then be able to approach the relevant lenders across a network of over 250 to source the right finance options in a timely manner. I am well-known to Pivotal Scientific and to a number of PSL Alliance members.

I can source Commercial Finance options in the following areas:
* Business Loans
* Asset, Equipment & Vehicles Finance
* Invoice Finance
* Refinancing
* Business Acquisition/MBO
* Property Finance - Commercial Mortgages; Bridging; Buy-to-Let; Property Development

With over 14 years of experience in the biotechnology and pharmaceutical sectors, I have established myself as a dynamic and results-driven leader, excelling in roles that demand strategic vision, scientific acumen, and exceptional project management skills. My career has been marked by significant contributions to drug discovery, innovation management, and business development, with a proven track record of driving growth and fostering client loyalty.

As Chief Business Officer in a CRO, I spearheaded business development initiatives, proactively engaging potential clients through targeted outreach campaigns. I successfully managed the entire sales cycle and secured contracts with biotech and major pharmaceutical companies. My ability to develop comprehensive proposals, aligning technical and financial aspects with client needs, ensured effective project management and client satisfaction. I represented the company's key assets at international congresses, further enhancing our market presence.

In my concurrent role as Chief Innovation Officer, I secured substantial funding for R&D projects through programs like Eurostar. My expertise in providing scientific and technical guidance to stakeholders has been instrumental in driving innovation and maintaining high standards of project execution.

Prior to these roles, as Chief Project Officer, I spearheaded drug discovery research projects, evaluating the efficacy, mechanism of action, and proof of concept for various candidates, including viruses, antibodies, small molecules, and vaccines. I managed cross-functional teams, budgets, timelines, and deliverables, ensuring project completion and regulatory compliance. My ability to analyze data and my deep expertise in flow cytometry, in vitro assays, immunology, mouse models and preclinical pharmacology evaluation allowed me to present comprehensive reports to clients and ensure project success and client satisfaction.

My academic foundation includes a PhD in immuno-oncology and a tenure as a Research Scientist at INSERM. I secured two post-doctoral grants and authored several peer-reviewed publications, further solidifying my scientific expertise.

Throughout my career, I have demonstrated a strong commitment to leadership, team collaboration, and client-centric approaches. My ability to fuse scientific knowledge with strategic business acumen has enabled me to drive impactful projects and foster long-term client relationships. I am eager to bring this unique blend of skills and experiences to new challenges, continuing to innovate and deliver exceptional results in the biotechnology and pharmaceutical sectors.